About

Discover ImaBiotech's various offers using cutting-edge Multimaging technology which combines Quantitative Mass Spectrometry Imaging and histology techniques to improve:

   Biomarker Disovery and Evaluations for many applications (Disease state or progression evaluations, efficacy or toxicity evaluations)
   Target engagement by QMSI allows the localization of the drug, metabolites and their pharmacological target without labelling
   Pharmacokinetics and Pharmacodynamics by QMSI provides drug and metabolites distribution with companion biomarkers at whole body or cellular levels
   Toxicity studies with QMSI identify the relation between drug, metabolites and toxicity at cellular levels, improve the chemical compounds and avoid NoGo decision at later stage Phase II